Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gardasil efficacy in Chinese women aged 20-45
NCT00834106Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2008
- Primary completion
- May 2012
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by Merck & Co.. Started Dec 2008; status: completed.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT00834106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00834106.